Synthesis of Carboxamide-Containing Tranylcypromine Analogues as LSD1 (KDM1A) Inhibitors Targeting Acute Myeloid Leukemia. 2021

Maria Teresa Borrello, and Hanae Benelkebir, and Adam Lee, and Chak Hin Tam, and Manar Shafat, and Stuart A Rushworth, and Kristian M Bowles, and Leon Douglas, and Patrick J Duriez, and Sarah Bailey, and Simon J Crabb, and Graham Packham, and A Ganesan
School of Pharmacy, University of East Anglia, Norwich, NR4 7TJ, UK.

Lysine-specific demethylase 1 (LSD1/KDM1A) oxidatively removes methyl groups from histone proteins, and its aberrant activity has been correlated with cancers including acute myeloid leukemia (AML). We report a novel series of tranylcypromine analogues with a carboxamide at the 4-position of the aryl ring. These compounds, such as 5 a and 5 b with benzyl and phenethylamide substituents, respectively, had potent sub-micromolar IC50 values for the inhibition of LSD1 as well as cell proliferation in a panel of AML cell lines. The dose-dependent increase in cellular expression levels of H3K4me2, CD86, CD11b and CD14 supported a mechanism involving LSD1 inhibition. The tert-butyl and ethyl carbamate derivatives of these tranylcypromines, although inactive in LSD1 inhibition, were of similar potency in cell-based assays with a more rapid onset of action. This suggests that carbamates can act as metabolically labile tranylcypromine prodrugs with superior pharmacokinetics.

UI MeSH Term Description Entries
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D014191 Tranylcypromine A propylamine formed from the cyclization of the side chain of amphetamine. This monoamine oxidase inhibitor is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in panic and phobic disorders. (From AMA Drug Evaluations Annual, 1994, p311) Jatrosom,Parnate,Transamine,Tranylcypromine Sulfate,trans-2-Phenylcyclopropylamine,Sulfate, Tranylcypromine,trans 2 Phenylcyclopropylamine
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D056466 Histone Demethylases Enzymes that catalyse the removal of methyl groups from LYSINE or ARGININE residues found on HISTONES. Many histone demethylases generally function through an oxidoreductive mechanism. Histone Demethylase,Histone Lysine Demethylase,Histone Arginine Demethylases,Histone Lysine Demethylases,Arginine Demethylases, Histone,Demethylase, Histone,Demethylase, Histone Lysine,Demethylases, Histone,Demethylases, Histone Arginine,Demethylases, Histone Lysine,Lysine Demethylase, Histone,Lysine Demethylases, Histone

Related Publications

Maria Teresa Borrello, and Hanae Benelkebir, and Adam Lee, and Chak Hin Tam, and Manar Shafat, and Stuart A Rushworth, and Kristian M Bowles, and Leon Douglas, and Patrick J Duriez, and Sarah Bailey, and Simon J Crabb, and Graham Packham, and A Ganesan
June 2011, Bioorganic & medicinal chemistry,
Maria Teresa Borrello, and Hanae Benelkebir, and Adam Lee, and Chak Hin Tam, and Manar Shafat, and Stuart A Rushworth, and Kristian M Bowles, and Leon Douglas, and Patrick J Duriez, and Sarah Bailey, and Simon J Crabb, and Graham Packham, and A Ganesan
June 2020, Bioorganic chemistry,
Maria Teresa Borrello, and Hanae Benelkebir, and Adam Lee, and Chak Hin Tam, and Manar Shafat, and Stuart A Rushworth, and Kristian M Bowles, and Leon Douglas, and Patrick J Duriez, and Sarah Bailey, and Simon J Crabb, and Graham Packham, and A Ganesan
April 2020, Science advances,
Maria Teresa Borrello, and Hanae Benelkebir, and Adam Lee, and Chak Hin Tam, and Manar Shafat, and Stuart A Rushworth, and Kristian M Bowles, and Leon Douglas, and Patrick J Duriez, and Sarah Bailey, and Simon J Crabb, and Graham Packham, and A Ganesan
July 2016, Expert opinion on investigational drugs,
Maria Teresa Borrello, and Hanae Benelkebir, and Adam Lee, and Chak Hin Tam, and Manar Shafat, and Stuart A Rushworth, and Kristian M Bowles, and Leon Douglas, and Patrick J Duriez, and Sarah Bailey, and Simon J Crabb, and Graham Packham, and A Ganesan
February 2021, Pharmacological research,
Maria Teresa Borrello, and Hanae Benelkebir, and Adam Lee, and Chak Hin Tam, and Manar Shafat, and Stuart A Rushworth, and Kristian M Bowles, and Leon Douglas, and Patrick J Duriez, and Sarah Bailey, and Simon J Crabb, and Graham Packham, and A Ganesan
January 2019, European journal of medicinal chemistry,
Maria Teresa Borrello, and Hanae Benelkebir, and Adam Lee, and Chak Hin Tam, and Manar Shafat, and Stuart A Rushworth, and Kristian M Bowles, and Leon Douglas, and Patrick J Duriez, and Sarah Bailey, and Simon J Crabb, and Graham Packham, and A Ganesan
May 2020, ACS medicinal chemistry letters,
Maria Teresa Borrello, and Hanae Benelkebir, and Adam Lee, and Chak Hin Tam, and Manar Shafat, and Stuart A Rushworth, and Kristian M Bowles, and Leon Douglas, and Patrick J Duriez, and Sarah Bailey, and Simon J Crabb, and Graham Packham, and A Ganesan
January 2022, Pharmacological research,
Maria Teresa Borrello, and Hanae Benelkebir, and Adam Lee, and Chak Hin Tam, and Manar Shafat, and Stuart A Rushworth, and Kristian M Bowles, and Leon Douglas, and Patrick J Duriez, and Sarah Bailey, and Simon J Crabb, and Graham Packham, and A Ganesan
June 2021, Bioorganic & medicinal chemistry letters,
Maria Teresa Borrello, and Hanae Benelkebir, and Adam Lee, and Chak Hin Tam, and Manar Shafat, and Stuart A Rushworth, and Kristian M Bowles, and Leon Douglas, and Patrick J Duriez, and Sarah Bailey, and Simon J Crabb, and Graham Packham, and A Ganesan
March 2021, European journal of medicinal chemistry,
Copied contents to your clipboard!